Clinical Trial Update: Symptom Assessment for Patients With Gastro-esophageal Reflux Disease Receiving Helicobacter Pylori Eradication [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update examining symptom assessment in patients with gastroesophageal reflux disease undergoing Helicobacter pylori eradication therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Gastroesophageal Reflux Disease | Phase 4 | Status: UNKNOWN